Repare Therapeutics Inc. (Nasdaq: RPTX), a clinical-stage precision oncology company, recently announced promising data from a study evaluating camonsertib, an oral small molecule ATR inhibitor, in combination with palliative radiation for treating metastatic tumors with an ataxia-telangiectasia-mutated (ATM) mutation. The…
Lupin Limited, a leading global pharmaceutical company, has announced that its subsidiary, Lupin Atlantis Holdings SA, has entered into a distribution agreement with Celnova Pharma for the commercialization of its orphan drug, NaMuscla® (mexiletine). Celnova will be responsible for distributing…
Artera, a pioneer in multimodal artificial intelligence (MMAI) for prognostic and predictive cancer testing, is set to present two oral abstracts at the 2024 American Society for Radiation Oncology (ASTRO) Annual Meeting. The company’s MMAI platform utilizes advanced AI algorithms…
eClinical Solutions LLC, a global leader in digital clinical software and services, is set to host its sixth annual client and partner conference, ENGAGE 2024, on Thursday, October 10 and Friday, October 11. This event will bring together top technology…
BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, announced that the U.S. Food and Drug Administration’s (FDA) Oncologic Drugs Advisory Committee (ODAC) has recognized the positive benefit-risk profile of PD-1 inhibitors, including TEVIMBRA® (tislelizumab-jsgr), for first-line…
In recognition of World Dense Breast Day on September 25, Bayer has announced a new study, published in Patient Preference and Adherence, that explores gaps in awareness and knowledge of breast cancer risk factors (BCRFs) among women with and without…
As British Columbians head to the polls on October 19, the Gastrointestinal Society is drawing attention to a critical issue: BC PharmaCare’s refusal to fund over 30 essential medications that are covered in most other provinces. This gap in coverage…
Omnicell, Inc. (Nasdaq: OMCL), a leader in transforming pharmacy care delivery, has announced the appointment of Nnamdi Njoku as Executive Vice President and Chief Operating Officer, effective October 7, 2024. In this newly created role, Njoku will report directly to…
a leading precision medicine company utilizing artificial intelligence (AI) to enhance cancer treatment, has announced its expansion into human oncology. Building on its successful work in veterinary oncology, ImpriMed will now offer precision medicine services for human blood cancers, including…
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) has announced the appointment of Catherine Owen Adams as its new Chief Executive Officer (CEO), succeeding Steve Davis. Adams will also join the company’s Board of Directors. “We are thrilled to welcome Catherine Owen Adams…
Aditxt, Inc. (NASDAQ: ADTX), an innovation-driven company focused on accelerating healthcare advancements, announced today that its majority-owned subsidiary, Pearsanta, Inc., has entered into a Market Development Collaboration Agreement with Evofem Biosciences, Inc. (OTCQB: EVFM), a leader in women’s health. This…
Negotiations on the world’s first agreement to safeguard people from future pandemics, led by the World Health Organization (WHO), made significant strides during the latest round of discussions, which concluded today. Key achievements of the 11th meeting of the Intergovernmental…